This study is about harm reduction (HR) practices for peolple who use anabolic androgenic steroids. It is a randomized controlled trial (RCT) that will compare a group that will receive an intervention in HR and another control (CTRL) that will receive usual guidelines. The primary outcome is the reduction in the final amount of drug consumed in relation to the initial planned amount. The secondary outcome is the understanding of what made the participants change their beliefs and change the planned pattern of AAS consumption.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Modulation of drug use
Timeframe: 2 months